<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2018.82031</article-id><article-id pub-id-type="publisher-id">ACM-24411</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20180200000_54606660.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  维生素D在神经系统疾病中的研究进展
  Advance in Research on Vitamin D of Neurological Disease
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>颖娴</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>赵</surname><given-names>洪芹</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>青岛大学附属医院神经内科，山东 青岛</addr-line></aff><aff id="aff2"><addr-line>青岛大学医学院，山东 青岛</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>15</day><month>03</month><year>2018</year></pub-date><volume>08</volume><issue>02</issue><fpage>185</fpage><lpage>189</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    维生素D是一种类固醇激素，除了传统的调节钙磷代谢作用外，还在人体免疫调控、细胞分化与增殖、神经保护等方面发挥显著作用。近年来研究发现，维生素D缺乏与多种神经系统疾病的发生发展相关。本文主要阐述维生素D在神经系统疾病如缺血性脑卒中、阿尔兹海默病、血管性痴呆、多发性硬化、帕金森病中的研究进展。
    Vitamin D is a steroid hormone. Besides the traditional regulation of calcium and phosphorus me-tabolism, it plays a significant role in immunoregulation, cell differentiation and proliferation, neuroprotection, etc. Recent studies have found that vitamin D deficiency is associated with the development of various neurological diseases. This paper is to review the research progress of Vitamin D in the neurological diseases, which include ischemic stroke, Alzheimer’s disease, vascular dementia, multiple sclerosis, and Parkinson’s disease. 
  
 
</p></abstract><kwd-group><kwd>维生素D，神经系统疾病, Vitamin D</kwd><kwd> Neurological Disease</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>维生素D在神经系统疾病中的研究进展<sup> </sup></title><p>张颖娴<sup>1</sup>，赵洪芹<sup>2</sup></p><p><sup>1</sup>青岛大学医学院，山东 青岛</p><p><sup>2</sup>青岛大学附属医院神经内科，山东 青岛</p><p><img src="//html.hanspub.org/file/15-1570500x1_hanspub.png" /></p><p>收稿日期：2018年3月19日；录用日期：2018年4月11日；发布日期：2018年4月18日</p><disp-formula id="hanspub.24411-formula19"><graphic xlink:href="//html.hanspub.org/file/15-1570500x5_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>维生素D是一种类固醇激素，除了传统的调节钙磷代谢作用外，还在人体免疫调控、细胞分化与增殖、神经保护等方面发挥显著作用。近年来研究发现，维生素D缺乏与多种神经系统疾病的发生发展相关。本文主要阐述维生素D在神经系统疾病如缺血性脑卒中、阿尔兹海默病、血管性痴呆、多发性硬化、帕金森病中的研究进展。</p><p>关键词 :维生素D，神经系统疾病</p><disp-formula id="hanspub.24411-formula20"><graphic xlink:href="//html.hanspub.org/file/15-1570500x6_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2018 by authors and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/15-1570500x7_hanspub.png" /> <img src="//html.hanspub.org/file/15-1570500x8_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>维生素D缺乏是一个全球性问题，据估计，全球约有10亿人存在维生素D缺乏或不足，这种问题在老年人群中更突出 [<xref ref-type="bibr" rid="hanspub.24411-ref1">1</xref>] 。维生素D是一种类固醇激素，主要由7一脱氢胆固醇在皮肤内经日光B型紫外线照射转变而来 [<xref ref-type="bibr" rid="hanspub.24411-ref2">2</xref>] ，其余少量来源于食物摄取。维生素D在肝脏中25-羟化酶的作用下羟基化，生成25(OH)D。25(OH)D在肾脏中被1-羟化酶水解成为1.25(OH)<sub>2</sub>D。维生素 D在体内的主要的储存形式为25(OH)D。1.25(OH)<sub>2</sub>D<sub>3</sub>是其在体内的唯一活性代谢产物 [<xref ref-type="bibr" rid="hanspub.24411-ref1">1</xref>] 。通常认为人体内的25(OH)D水平在30 nmol/l~50 nmol/l为正常；20~30 nmol/l为维生素D不足；&lt;20 nmol/l为维生素D缺乏。越来越多的证据表明，维生素D作为传统的调节钙磷代谢物质，除有促进生长和骨骼钙化作用外，还在人体免疫调控、细胞分化与增殖、神经保护等方面发挥显著作用。大量研究表明维生素D与神经系统相关疾病密切相关。本文就维生素D在缺血性脑卒中、阿尔兹海默病、血管性痴呆、多发性硬化、帕金森氏病等方面的研究进展进行综述。</p></sec><sec id="s4"><title>2. 维生素D与神经系统疾病</title><sec id="s4_1"><title>2.1. 维生素D与缺血性脑卒中的作用</title><p>缺血性脑卒中具有高发病率、高致残率及高病死率特点，是威胁人类健康的主要疾病之一 [<xref ref-type="bibr" rid="hanspub.24411-ref3">3</xref>] 。大量研究发现25(OH)D浓度与缺血性卒中的风险增加直接相关 [<xref ref-type="bibr" rid="hanspub.24411-ref4">4</xref>] 。低水平血浆25(OH)D与一些目前已确定的缺血性卒中危险因素有关，如高血压、血栓形成、动脉粥样硬化和炎症等 [<xref ref-type="bibr" rid="hanspub.24411-ref5">5</xref>] 。维生素D与缺血性卒中相关的机制包括以下几个方面：1) 25(OH)D通过影响缺血性卒中的传统危险因素，从而影响缺血性卒中的发病风险。除年龄外，高血压是缺血性卒中最重要的危险因素 [<xref ref-type="bibr" rid="hanspub.24411-ref6">6</xref>] 。研究表明低水平25(OH)D可导致肾素转录基因水平升高，从而导致高血压，诱发缺血性脑卒中 [<xref ref-type="bibr" rid="hanspub.24411-ref7">7</xref>] 。同时导致动脉粥样硬化和心房颤动，从而促进脑栓塞发生。2) 血栓形成：在维生素D受体敲除的小鼠中发现血栓调节蛋白上调及组织因子表达下调，从而增加血栓形成 [<xref ref-type="bibr" rid="hanspub.24411-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.24411-ref9">9</xref>] 。3) 动脉粥样硬化：有研究表明血清25(OH)D水平下降与血管内皮功能紊乱、血脂代谢异常、血管氧化应激等相关，从而导致颈内动脉内膜–中膜厚度增加、管腔狭窄 [<xref ref-type="bibr" rid="hanspub.24411-ref10">10</xref>] 。4) 炎症：从血栓形成的起始、进展再到最终形成，炎症反应在动脉粥样硬化的各个阶段都起着重要作用。血浆25(OH)D浓度降低与炎症反应增加有关 [<xref ref-type="bibr" rid="hanspub.24411-ref11">11</xref>] 。另外流行病学研究发现，维生素D浓度与心血管疾病发生呈U型相关，较低或较高的血浆维生素D浓度个体心血管疾病的发生风险均增加。</p></sec><sec id="s4_2"><title>2.2. 维生素D与认知障碍的作用</title><sec id="s4_2_1"><title>2.2.1. 阿尔兹海默病</title><p>阿尔兹海默病是一种以进行性认知功能下降为主要表现的慢性进行性神经系统变性疾病，是老年人痴呆的最常见原因 [<xref ref-type="bibr" rid="hanspub.24411-ref12">12</xref>] 。它由多种病理生理机制共同作用引起，包括蛋白质(包括淀粉样蛋白和tau蛋白衍生物)沉积、神经纤维缠绕、谷氨酸神经毒性、氧化应激和引起神经、突触退行性变的免疫炎症反应等 [<xref ref-type="bibr" rid="hanspub.24411-ref13">13</xref>] 。研究表明，随着血浆25(OH)D水平降低，阿尔兹海默病的发生风险增加 [<xref ref-type="bibr" rid="hanspub.24411-ref14">14</xref>] ，补充维生素D可降低AD的发病风险 [<xref ref-type="bibr" rid="hanspub.24411-ref15">15</xref>] 。Matthew R. Durk等人 [<xref ref-type="bibr" rid="hanspub.24411-ref16">16</xref>] 发现在阿尔兹海默病型小鼠模型中，维生素D可以减少脑β淀粉样蛋白沉积，从而提高小鼠认知能力，延缓神经元细胞死亡。研究表明，维生素D通过控制细胞内氧和一氧化氮反应产生自由基、抑制诱导型一氧化氮合酶的合成，同时调节谷胱甘肽抗氧化代谢的关键酶-g-谷氨酰转肽酶的活性，从而稳定线粒体，减少细胞的氧化损伤 [<xref ref-type="bibr" rid="hanspub.24411-ref17">17</xref>] 。另外维生素D还通过增加钙蛋白或血浆Ca<sup>2+</sup> ATP酶或通过下调L型电压敏感型钙通道，从而调节内源性钙稳态，减少细胞凋亡 [<xref ref-type="bibr" rid="hanspub.24411-ref18">18</xref>] 。此外，维生素D还能调节海马区炎症反应 [<xref ref-type="bibr" rid="hanspub.24411-ref19">19</xref>] 及神经营养因子的遗传表达 [<xref ref-type="bibr" rid="hanspub.24411-ref20">20</xref>] ，增强阿尔兹海默病患者的神经保护作用。</p></sec><sec id="s4_2_2"><title>2.2.2. 血管性痴呆</title><p>血管性痴呆是痴呆的另一种常见类型。脑卒中是引起血管性痴呆的主要原因。临床研究表明，维生素D缺乏可增加脑卒中风险，与血管性痴呆患者脑白质高信号有关 [<xref ref-type="bibr" rid="hanspub.24411-ref14">14</xref>] ，而高水平血浆25(OH)D可能会减小梗死面积 [<xref ref-type="bibr" rid="hanspub.24411-ref21">21</xref>] 。高血压、糖尿病、高脂血症是缺血性卒中的主要危险因素，维生素D缺乏可增加高血压、糖尿病、高脂血症的风险性，从而增加血管性痴呆的患病风险 [<xref ref-type="bibr" rid="hanspub.24411-ref14">14</xref>] 。</p></sec></sec><sec id="s4_3"><title>2.3. 与多发性硬化</title><p>多发性硬化症(multiple sclerosis, MS)是一种中枢神经系统脱髓鞘性自身免疫性疾病，主要影响中枢神经系统白质，以视力障碍、中枢性瘫痪、感觉障碍、共济失调、认知障碍、疲劳和睡眠障碍为主要表现 [<xref ref-type="bibr" rid="hanspub.24411-ref22">22</xref>] 。多见于青中年，其中女性发病率是男性的两倍，具有较高的致残率。国内外研究结果显示，与对照组相比，MS组维生素D水平较低；复发期MS患者维生素D水平较缓解期低；维生素D水平降低与核磁新发T2病灶增多有关 [<xref ref-type="bibr" rid="hanspub.24411-ref23">23</xref>] 。维生素D通过与维生素D受体(VDR)结合，与类视黄醇X受体形成异源二聚体，参与调控基因转录，从而降低Th1型细胞活性，减少IFN-γ的分泌；升高Th2型细胞活性，增加IL-4，IL-10的分泌 [<xref ref-type="bibr" rid="hanspub.24411-ref24">24</xref>] 。同时1.25(OH)D能抑制CD4 + T细胞向Th17细胞的分化，控制Th17细胞向中枢神经系统迁移 [<xref ref-type="bibr" rid="hanspub.24411-ref25">25</xref>] ，抑制Th17细胞分泌IL-17 [<xref ref-type="bibr" rid="hanspub.24411-ref26">26</xref>] ，从而发挥抗炎及自身免疫调节作用，延缓MS的进展。此外维生素D还可与中枢神经系统内神经元、星形胶质细胞、少突胶质细胞及小胶质细胞中与其VDR结合，从而发挥神经保护、神经营养、再髓鞘化等作用。</p></sec><sec id="s4_4"><title>2.4. 维生素D与帕金森病 (PD)的作用</title><p>帕金森病 (PD)是一种以黑质纹状体多巴胺能神经元变性为主要原因的中枢神经系统退行性病变，临床表现主要为静止性震颤、肌僵直、运动迟缓、姿势和步态异常。主要生物化学特征为脑内多巴胺减少。维生素D能增加黑质和纹状体产生神经营养因子GDNF的速度，保护多巴胺能神经元免受细胞毒性物质损伤。Niu et al. [<xref ref-type="bibr" rid="hanspub.24411-ref27">27</xref>] 等人发现维生素D受体(VDR) Fokl基因位点CC基因型与PD存在相关性。T&#246;r&#246;k et al. [<xref ref-type="bibr" rid="hanspub.24411-ref28">28</xref>] 在匈牙利人群中选取了100例PD患者及109例健康对照者，探讨VDR五个基因多态性和PD的关系，结果表明Fokl位点等位基因C与PD有相关性。然而目前关于维生素D与PD相关性的研究结果并不一致。</p></sec><sec id="s4_5"><title>2.5. 维生素D与神经系统其他疾病</title><p>此外，研究表明维生素D还在癫痫、视神经脊髓炎、肌萎缩侧索硬化、亨廷顿氏病、周围神经病变的发生、发展中起重要作用，其机制可能与维生素D调节白细胞介素、促进胶质细胞产生神经营养因子及对神经元的神经保护作用有关。</p></sec></sec><sec id="s5"><title>3. 小结</title><p>维生素D缺乏在神经系统疾病如缺血性脑卒中、阿尔兹海默病、血管性痴呆、多发性硬化、帕金森氏病等的发生发展中的多个环节发挥重要作用。但目前维生素D在生理病理条件下对神经系统的调节机制研究并不十分透彻，且补充维生素D后对上述疾病的影响作用结论并不一致，因此仍有待开展更多神经系统疾病模型补充维生素D的研究，为维生素D预防和治疗神经系统疾病提供更多的理论依据。</p></sec><sec id="s6"><title>文章引用</title><p>张颖娴,赵洪芹. 维生素D在神经系统疾病中的研究进展 Advance in Research on Vitamin D of Neurological Disease[J]. 临床医学进展, 2018, 08(02): 185-189. https://doi.org/10.12677/ACM.2018.82031</p></sec><sec id="s7"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.24411-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Sahota, O. (2014) Understanding Vitamin D Deficiency. Age and Ageing, 43, 589-591.  
https://doi.org/10.1093/ageing/afu104</mixed-citation></ref><ref id="hanspub.24411-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">McGrath, J.J., et al. (2010) A Systematic Review of the Association between Common Single Nucleotide Polymorphisms and 25-Hydroxyvitamin D Concentrations. The Journal of Steroid Biochemistry and Molecular Biology, 121, 471-477. https://doi.org/10.1016/j.jsbmb.2010.03.073</mixed-citation></ref><ref id="hanspub.24411-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Go, A.S., et al. (2014) Heart Disease and Stroke Statistics—2014 Update: A Report from the American Heart Association. Circulation, 129, e28-e292. https://doi.org/10.1161/01.cir.0000441139.02102.80</mixed-citation></ref><ref id="hanspub.24411-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Brondum-Jacobsen, P., et al. (2013) 25-Hydroxyvitamin D and Symptomatic Ischemic Stroke: An Original Study and Meta-Analysis. Annals of Neurology, 73, 38-47. https://doi.org/10.1002/ana.23738</mixed-citation></ref><ref id="hanspub.24411-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Pilz, S., et al. (2011) Vitamin D Supplementation: A Promising Approach for the Prevention and Treatment of Strokes. Current Drug Targets, 12, 88-96. https://doi.org/10.2174/138945011793591563</mixed-citation></ref><ref id="hanspub.24411-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Sierra, C., Coca, A. and Schiffrin, E.L. (2011) Vascular Mechanisms in the Pathogenesis of Stroke. Current Hypertension Reports, 13, 200-207. https://doi.org/10.1007/s11906-011-0195-x</mixed-citation></ref><ref id="hanspub.24411-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Li, Y.C., et al. (2004) Vitamin D: A Negative Endocrine Regu-lator of the Renin-Angiotensin System and Blood Pressure. Journal of Steroid Biochemistry &amp; Molecular Biology, 89-90, 387-392.  
https://doi.org/10.1016/j.jsbmb.2004.03.004</mixed-citation></ref><ref id="hanspub.24411-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ohsawa, M., et al. (2000) 1α,25-Dihydroxyvitamin D(3) and Its Potent Synthetic Analogs Downregulate Tissue Factor and Upregulate Thrombomodulin Expression in Monocytic Cells, Counteracting the Effects of Tumor Necrosis Factor and Oxidized LDL. Circulation, 102, 2867-2872. https://doi.org/10.1161/01.CIR.102.23.2867</mixed-citation></ref><ref id="hanspub.24411-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Aihara, K., et al. (2004) Disruption of Nuclear Vitamin D Re-ceptor Gene Causes Enhanced Thrombogenicity in Mice. The Journal of Biological Chemistry, 279, 35798-35802. https://doi.org/10.1074/jbc.M404865200</mixed-citation></ref><ref id="hanspub.24411-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Strawbridge, R.J., et al. (2014) A Serum 25-Hydroxyvitamin D Concentration-Associated Genetic Variant in DHCR7 Interacts with Type 2 Diabetes Status to Influence Subclinical Atherosclerosis (Measured by Carotid Intima-Media Thickness). Diabetologia, 57, 1159-1172.</mixed-citation></ref><ref id="hanspub.24411-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bobryshev, Y.V. (2010) Vitamin D3 Suppresses Immune Reactions in Atherosclerosis, Affecting Regulatory T Cells and Dendritic Cell Function. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 2317-2319.  
https://doi.org/10.1161/ATVBAHA.110.217141</mixed-citation></ref><ref id="hanspub.24411-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Montine, T.J., et al. (2014) Recommendations of the Alz-heimer’s Disease-Related Dementias Conference. Neurology, 83, 851-860. https://doi.org/10.1212/WNL.0000000000000733</mixed-citation></ref><ref id="hanspub.24411-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Querfurth, H.W. and LaFerla, F.M. (2010) Alzheimer’s Disease. The New England Journal of Medicine, 362, 329-344.  
https://doi.org/10.1056/NEJMra0909142</mixed-citation></ref><ref id="hanspub.24411-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Afzal, S., Bojesen, S.E. and Nordestgaard, B.G. (2014) Reduced 25-Hydroxyvitamin D and Risk of Alzheimer’s Disease and Vascular Dementia. Alzheimer’s &amp; Dementia, 10, 296-302. https://doi.org/10.1016/j.jalz.2013.05.1765</mixed-citation></ref><ref id="hanspub.24411-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Annweiler, C., et al. (2012) Higher Vitamin D Dietary Intake Is Associated with Lower Risk of Alzheimer’s Disease: A 7-Year Follow-Up. Journals of Gerontology: Series A-Biological Sciences and Medical Sciences, 67, 1205-1211.  
https://doi.org/10.1093/gerona/gls107</mixed-citation></ref><ref id="hanspub.24411-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Durk, M.R., et al. (2014) 1α,25-Dihydroxyvitamin D3 Reduces Cer-ebral Amyloid-Beta Accumulation and Improves Cognition in Mouse Models of Alzheimer’s Disease. Journal of Neuroscience, 34, 7091-7101.  
https://doi.org/10.1523/JNEUROSCI.2711-13.2014</mixed-citation></ref><ref id="hanspub.24411-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Lemire, P., et al. (2018) Cognitive Changes under Me-mantine According to Vitamin D Status in Alzheimer Patients: An Exposed/Unexposed Cohort Pilot Study. The Journal of Steroid Biochemistry and Molecular Biology, 175, 151-156.  
https://doi.org/10.1016/j.jsbmb.2016.12.019</mixed-citation></ref><ref id="hanspub.24411-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Lương, K.V.O. and Nguyễn, L.T.H. (2013) The Role of vitamin D in Alzheimer’s Disease: Possible Genetic and Cell Signaling Mechanisms. American Journal of Alzheimer’s Disease &amp; Other Dementias, 28, 126-136.  
https://doi.org/10.1177/1533317512473196</mixed-citation></ref><ref id="hanspub.24411-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Moore, M.E., et al. (2005) Evidence That Vitamin D3 Reverses Age-Related Inflammatory Changes in the Rat Hippocampus. Biochemical Society Transactions, 33, 573-577. https://doi.org/10.1042/BST0330573</mixed-citation></ref><ref id="hanspub.24411-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Brown, J., et al. (2003) 1,25-Dihydroxyvitamin D3 Induces Nerve Growth Factor, Promotes Neurite Outgrowth and Inhibits Mitosis in Embryonic rat Hippocampal Neurons. Neuroscience Letters, 343, 139-143.  
https://doi.org/10.1016/S0304-3940(03)00303-3</mixed-citation></ref><ref id="hanspub.24411-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Y., et al. (2000) Vitamin D(3) Attenuates Cortical Infarction Induced by Middle Cerebral Arterial Ligation in Rats. Neuropharmacology, 39, 873-880. https://doi.org/10.1016/S0028-3908(99)00255-5</mixed-citation></ref><ref id="hanspub.24411-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Compston, A. and Coles, A. (2008) Multiple Sclerosis. The Lancet, 372, 1502-1517.  
https://doi.org/10.1016/S0140-6736(08)61620-7</mixed-citation></ref><ref id="hanspub.24411-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">侯凡芳, 李豪杰. 血清中维生素D水平与多发性硬化关系的系统评价[J]. 中国药物与临床, 2015, 15(3): 312-315.</mixed-citation></ref><ref id="hanspub.24411-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Yang, C.Y., et al. (2013) The Implication of Vitamin D and Autoimmunity: A Comprehensive Review. Clinical Reviews in Allergy &amp; Immunology, 45, 217-226. https://doi.org/10.1007/s12016-013-8361-3</mixed-citation></ref><ref id="hanspub.24411-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Chang, J.H., et al. (2010) 1,25-Dihydroxyvitamin D3 Inhibits the Differentiation and Migration of T(H)17 Cells to Protect against Experimental Autoimmune Encephalomyelitis. PLoS ONE, 5, e12925.  
https://doi.org/10.1371/journal.pone.0012925</mixed-citation></ref><ref id="hanspub.24411-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Joshi, S., et al. (2011) 1,25-Dihydroxyvitamin D(3) Amelio-rates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A. Molecular and Cellular Biology, 31, 3653-3669. https://doi.org/10.1128/MCB.05020-11</mixed-citation></ref><ref id="hanspub.24411-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Li, C., et al. (2015) Vitamin D Receptor Gene Poly-morphisms and the Risk of Parkinson’s Disease. Neurological Sciences, 36, 247-255. https://doi.org/10.1007/s10072-014-1928-9</mixed-citation></ref><ref id="hanspub.24411-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Török, R., et al. (2013) Association of Vitamin D Receptor Gene Polymorphisms and Parkinson’s Disease in Hungarians. Neuroscience Letters, 551, 70-74. https://doi.org/10.1016/j.neulet.2013.07.014</mixed-citation></ref></ref-list></back></article>